Alere and Malaria No More Provide One Million Rapid Malaria Tests to Children
WALTHAM, Mass., April 25, 2014
WALTHAM, Mass., April 25, 2014 /PRNewswire/ --Alere Inc. (NYSE: ALR), a
global leader in empowering individuals to take greater control of their
health at home by connecting innovative diagnostics in the hands of patients
to their healthcare providers, announced today that it is completing the
delivery of one million rapid malaria tests in Zambia. The donated tests are
part of an ongoing collaboration with Malaria No More, a global non-profit
determined to end malaria deaths, on its Power of One campaign to raise funds
to deliver life-saving tests and treatment to children in Africa where the
disease burden is highest.
"As we observe World Malaria Day 2014, it is important to recognize the
considerable progress global efforts have made to control and eliminate
malaria," said Avi Pelossof, Global President of Infectious Disease at Alere.
"Yet, despite that progress malaria still kills an estimated 627,000 people
every year, mainly children under the age of 5 years in sub-Saharan Africa.
Alere is deeply committed to working with partners such as Malaria No More to
defeat malaria by improving access to diagnostic testing and treatments for
Alere, as exclusive diagnostics partner to Malaria No More, will donate a
total of two million of its Alere SD BIOLINE Malaria Rapid tests over the
course of the Power of One campaign. With test results in 15 minutes from a
drop of finger stick blood, the Alere SD BIOLINE Malaria test can accurately
diagnose malaria to enable timely treatment with the potential to save a life.
Malaria is a major public health problem in Zambia and has been one of the
leading causes of morbidity and mortality in the country. Of all people who
die from malaria in Zambia (approximately 8,000 per year), 50 percent or more
are children under 5 years of age.^2 Strong partnerships such as the one with
Malaria No More have helped Zambia make considerable progress in the fight
against malaria by implementing effective malaria prevention, testing,
treatment, and care interventions. ^
By developing new capabilities in near-patient diagnosis, monitoring and
health information technology, Alere enables individuals to take charge of
improving their health and quality of life at home. Alere's global leading
products and services, as well as its new product development efforts, focus
on infectious disease, toxicology, cardiology and diabetes. Alere is
headquartered in Waltham, Massachusetts. For more information regarding Alere,
please visit www.alere.com.
^1World Health Organization, World Malaria Day, 25 April 2014,
SOURCE Alere Inc.
Contact: Jackie Lustig, Director, Corporate Communications,
Press spacebar to pause and continue. Press esc to stop.